See every side of every news story
Published loading...Updated

trū® Chitosan Files Patent on New USP Inhalant Product

Summary by abc12/WJRT
BALATON, Minn., July 15, 2025 /PRNewswire/ -- trū® Chitosan, a brand of iterro Life Sciences, announced the introduction of trū Chitosan USP Inhalant—the first commercially available chitosan qualified for inhaled drug delivery, based on USP and USP 232 standards.

26 Articles

abc12/WJRTabc12/WJRT
+25 Reposted by 25 other sources
Center

trū® Chitosan Files Patent on New USP Inhalant Product

BALATON, Minn., July 15, 2025 /PRNewswire/ -- trū® Chitosan, a brand of iterro Life Sciences, announced the introduction of trū Chitosan USP Inhalant—the first commercially available chitosan qualified for inhaled drug delivery, based on USP and USP 232 standards.

·Flint, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 93% of the sources are Center
93% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

abc12/WJRT broke the news in Flint, United States on Tuesday, July 15, 2025.
Sources are mostly out of (0)

Similar News Topics